Identification and Experimental Validation of NOP10 as a Biomarker for Diffuse Large B-Cell Lymphoma
Our study has identified NOP10 as a promising biomarker of DLBCL, providing potential insights into the molecular mechanisms underlying this disease. Moreover, a multi-method approach integrating microarray analysis, MR, and experimental validation has established a robust framework for advancing biomarker discovery and identifying therapeutic targets for various diseases.
Authors
- Yidong Zhu
- Ling‐Yun He (ORCID: https://orcid.org/0000-0003-3565-9422)
- Ting Zhang
Institutions
- Tongji University (CN)
- Shanghai Tenth People's Hospital (CN)
- Jiangsu Province Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Current Gene Therapy
- Published
- 2026-01-08
- DOI
- https://doi.org/10.2174/0115665232412079251105074524
- Citations
- 1
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 36.00